Shire PLC (LON:SHP) has been assigned an average rating of “Buy” from the nineteen ratings firms that are covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is GBX 5,875.60 ($76.28).

SHP has been the topic of a number of analyst reports. Barclays PLC reissued an “overweight” rating and set a GBX 6,300 ($81.79) price objective on shares of Shire PLC in a report on Monday, July 3rd. Beaufort Securities reissued a “long term buy” rating and set a GBX 4,900 ($63.61) price objective (down previously from GBX 6,200 ($80.49)) on shares of Shire PLC in a report on Friday, August 4th. J P Morgan Chase & Co reissued an “overweight” rating and set a GBX 6,000 ($77.89) price objective on shares of Shire PLC in a report on Friday, May 19th. Credit Suisse Group reissued an “outperform” rating and set a GBX 5,400 ($70.10) price objective on shares of Shire PLC in a report on Wednesday, May 3rd. Finally, Deutsche Bank AG reissued a “buy” rating and set a GBX 6,100 ($79.19) price objective on shares of Shire PLC in a report on Friday, May 19th.

In other news, insider Dominic Blakemore acquired 152 shares of Shire PLC stock in a transaction on Friday, June 30th. The stock was bought at an average price of GBX 4,255 ($55.24) per share, for a total transaction of £6,467.60 ($8,396.21).

TRADEMARK VIOLATION WARNING: “Shire PLC (SHP) Given Consensus Recommendation of “Buy” by Analysts” was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at

Shire PLC (LON SHP) traded down 2.75% during trading on Friday, reaching GBX 3764.50. The company had a trading volume of 2,171,107 shares. The stock has a 50 day moving average of GBX 4,123.50 and a 200-day moving average of GBX 4,503.35. Shire PLC has a 12 month low of GBX 3,738.50 and a 12 month high of GBX 5,377.00. The company’s market capitalization is GBX 34.12 billion.

The company also recently disclosed a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be given a GBX 3.85 ($0.05) dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a dividend yield of 0.1%.

Shire PLC Company Profile

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Analyst Recommendations for Shire PLC (LON:SHP)

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with's FREE daily email newsletter.